Cargando…
Effects of intensified conditioning on Epstein-Barr virus and cytomegalovirus infections in allogeneic hematopoietic stem cell transplantation for hematological malignancies
BACKGROUND: Intensified conditioning regimens (increasing the intensity of standard myeloablative conditioning) for hematological malignancies in allogeneic hematopoietic stem cell transplantation (allo-HSCT) could reduce the relapse rate of the underlying disease, but it might simultaneously increa...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3422173/ https://www.ncbi.nlm.nih.gov/pubmed/22856463 http://dx.doi.org/10.1186/1756-8722-5-46 |
_version_ | 1782241004483510272 |
---|---|
author | Xuan, Li Huang, Fen Fan, Zhiping Zhou, Hongsheng Zhang, Xian Yu, Guopan Zhang, Yu Liu, Can Sun, Jing Liu, Qifa |
author_facet | Xuan, Li Huang, Fen Fan, Zhiping Zhou, Hongsheng Zhang, Xian Yu, Guopan Zhang, Yu Liu, Can Sun, Jing Liu, Qifa |
author_sort | Xuan, Li |
collection | PubMed |
description | BACKGROUND: Intensified conditioning regimens (increasing the intensity of standard myeloablative conditioning) for hematological malignancies in allogeneic hematopoietic stem cell transplantation (allo-HSCT) could reduce the relapse rate of the underlying disease, but it might simultaneously increase the transplant-related mortality including the mortality of infections. To explore whether intensified conditioning affected Epstein-Barr virus (EBV) and cytomegalovirus (CMV) infections, 185 patients undergoing allo-HSCT were enrolled. METHODS: A total of 104 cases received standard and 81 intensified conditioning. Cyclosporine A (CsA) withdrawal and/or donor lymphocyte infusion (DLI) were conducted in high-risk patients. The EBV-DNA and CMV-DNA levels of blood were monitored regularly by quantitative real-time polymerase chain reaction (RQ-PCR) and immune reconstitution of recipients were analyzed by flow cytometry. RESULTS: The 3-year cumulative incidence of EBV viremia, EBV-associated diseases and mortality of EBV-associated diseases were 25.3% ± 4.6%, 10.5% ± 3.4% and 0.0% ± 0.0% in the standard group, compared with 45.6% ± 6.5%, 26.0% ±5.3% and 7.3% ± 3.1% in the intensified group (P = 0.002, P = 0.002, P = 0.008). The 3-year cumulative incidence of CMV viremia and CMV-associated diseases, mortality of CMV-associated diseases and incidence of bacterial and fungal infections were similar between the two groups (P = 0.855, P = 0.581, P = 0.933, P = 0.142, P = 0.182, respectively). Multivariate analysis showed that intensified conditioning was one of the risk factors for EBV viremia and EBV-associated diseases (P = 0.037, P = 0.037), but it had no effects on CMV infections. The percentage of CD4(+) T cells and CD4(+)/CD8(+) ratio at 3 months post-transplantation were lower in the intensified group (P = 0.032, P = 0.022). The 3-year OS and DFS in the standard group were 62.2% ± 5.8% and 60.6% ± 5.6%, compared with 51.6% ± 6.2% and 51.1% ± 5.9% in the intensified group (P = 0.029, P = 0.063). CONCLUSIONS: Intensified conditioning represents a promising approach for high-risk hematological malignancies, although it affects early immune reconstitution of recipients and increases the incidence and mortality of EBV infections. |
format | Online Article Text |
id | pubmed-3422173 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-34221732012-08-18 Effects of intensified conditioning on Epstein-Barr virus and cytomegalovirus infections in allogeneic hematopoietic stem cell transplantation for hematological malignancies Xuan, Li Huang, Fen Fan, Zhiping Zhou, Hongsheng Zhang, Xian Yu, Guopan Zhang, Yu Liu, Can Sun, Jing Liu, Qifa J Hematol Oncol Research BACKGROUND: Intensified conditioning regimens (increasing the intensity of standard myeloablative conditioning) for hematological malignancies in allogeneic hematopoietic stem cell transplantation (allo-HSCT) could reduce the relapse rate of the underlying disease, but it might simultaneously increase the transplant-related mortality including the mortality of infections. To explore whether intensified conditioning affected Epstein-Barr virus (EBV) and cytomegalovirus (CMV) infections, 185 patients undergoing allo-HSCT were enrolled. METHODS: A total of 104 cases received standard and 81 intensified conditioning. Cyclosporine A (CsA) withdrawal and/or donor lymphocyte infusion (DLI) were conducted in high-risk patients. The EBV-DNA and CMV-DNA levels of blood were monitored regularly by quantitative real-time polymerase chain reaction (RQ-PCR) and immune reconstitution of recipients were analyzed by flow cytometry. RESULTS: The 3-year cumulative incidence of EBV viremia, EBV-associated diseases and mortality of EBV-associated diseases were 25.3% ± 4.6%, 10.5% ± 3.4% and 0.0% ± 0.0% in the standard group, compared with 45.6% ± 6.5%, 26.0% ±5.3% and 7.3% ± 3.1% in the intensified group (P = 0.002, P = 0.002, P = 0.008). The 3-year cumulative incidence of CMV viremia and CMV-associated diseases, mortality of CMV-associated diseases and incidence of bacterial and fungal infections were similar between the two groups (P = 0.855, P = 0.581, P = 0.933, P = 0.142, P = 0.182, respectively). Multivariate analysis showed that intensified conditioning was one of the risk factors for EBV viremia and EBV-associated diseases (P = 0.037, P = 0.037), but it had no effects on CMV infections. The percentage of CD4(+) T cells and CD4(+)/CD8(+) ratio at 3 months post-transplantation were lower in the intensified group (P = 0.032, P = 0.022). The 3-year OS and DFS in the standard group were 62.2% ± 5.8% and 60.6% ± 5.6%, compared with 51.6% ± 6.2% and 51.1% ± 5.9% in the intensified group (P = 0.029, P = 0.063). CONCLUSIONS: Intensified conditioning represents a promising approach for high-risk hematological malignancies, although it affects early immune reconstitution of recipients and increases the incidence and mortality of EBV infections. BioMed Central 2012-08-02 /pmc/articles/PMC3422173/ /pubmed/22856463 http://dx.doi.org/10.1186/1756-8722-5-46 Text en Copyright ©2012 Xuan et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Xuan, Li Huang, Fen Fan, Zhiping Zhou, Hongsheng Zhang, Xian Yu, Guopan Zhang, Yu Liu, Can Sun, Jing Liu, Qifa Effects of intensified conditioning on Epstein-Barr virus and cytomegalovirus infections in allogeneic hematopoietic stem cell transplantation for hematological malignancies |
title | Effects of intensified conditioning on Epstein-Barr virus and cytomegalovirus infections in allogeneic hematopoietic stem cell transplantation for hematological malignancies |
title_full | Effects of intensified conditioning on Epstein-Barr virus and cytomegalovirus infections in allogeneic hematopoietic stem cell transplantation for hematological malignancies |
title_fullStr | Effects of intensified conditioning on Epstein-Barr virus and cytomegalovirus infections in allogeneic hematopoietic stem cell transplantation for hematological malignancies |
title_full_unstemmed | Effects of intensified conditioning on Epstein-Barr virus and cytomegalovirus infections in allogeneic hematopoietic stem cell transplantation for hematological malignancies |
title_short | Effects of intensified conditioning on Epstein-Barr virus and cytomegalovirus infections in allogeneic hematopoietic stem cell transplantation for hematological malignancies |
title_sort | effects of intensified conditioning on epstein-barr virus and cytomegalovirus infections in allogeneic hematopoietic stem cell transplantation for hematological malignancies |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3422173/ https://www.ncbi.nlm.nih.gov/pubmed/22856463 http://dx.doi.org/10.1186/1756-8722-5-46 |
work_keys_str_mv | AT xuanli effectsofintensifiedconditioningonepsteinbarrvirusandcytomegalovirusinfectionsinallogeneichematopoieticstemcelltransplantationforhematologicalmalignancies AT huangfen effectsofintensifiedconditioningonepsteinbarrvirusandcytomegalovirusinfectionsinallogeneichematopoieticstemcelltransplantationforhematologicalmalignancies AT fanzhiping effectsofintensifiedconditioningonepsteinbarrvirusandcytomegalovirusinfectionsinallogeneichematopoieticstemcelltransplantationforhematologicalmalignancies AT zhouhongsheng effectsofintensifiedconditioningonepsteinbarrvirusandcytomegalovirusinfectionsinallogeneichematopoieticstemcelltransplantationforhematologicalmalignancies AT zhangxian effectsofintensifiedconditioningonepsteinbarrvirusandcytomegalovirusinfectionsinallogeneichematopoieticstemcelltransplantationforhematologicalmalignancies AT yuguopan effectsofintensifiedconditioningonepsteinbarrvirusandcytomegalovirusinfectionsinallogeneichematopoieticstemcelltransplantationforhematologicalmalignancies AT zhangyu effectsofintensifiedconditioningonepsteinbarrvirusandcytomegalovirusinfectionsinallogeneichematopoieticstemcelltransplantationforhematologicalmalignancies AT liucan effectsofintensifiedconditioningonepsteinbarrvirusandcytomegalovirusinfectionsinallogeneichematopoieticstemcelltransplantationforhematologicalmalignancies AT sunjing effectsofintensifiedconditioningonepsteinbarrvirusandcytomegalovirusinfectionsinallogeneichematopoieticstemcelltransplantationforhematologicalmalignancies AT liuqifa effectsofintensifiedconditioningonepsteinbarrvirusandcytomegalovirusinfectionsinallogeneichematopoieticstemcelltransplantationforhematologicalmalignancies |